Recent Company News

• 02:25 AM ET Feb 06, 2025
  

  Angle PLC announces novel findings using Parsortix (15.7000p, 0)

• 04:27 AM ET Nov 15, 2024
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:21 AM ET Jan 29, 2025
  

  ANGLE notes new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform (13.2500p, 0)

• 05:08 AM ET Jan 24, 2025
  

  Angle PLC's Parsortix used in research paper from ETH Zurich (11.5000p, -0.5)

• 02:21 AM ET Jan 23, 2025
  

  ANGLE FY Trading Update: revenue £2.9M vs year-ago £2.2M (13.0000p, 0)

• 03:51 AM ET Dec 13, 2024
  

  ANGLE to present an independent study, reporting on a novel, Parsortix-based HER2 workflow, at San Antonio Breast Cancer Symposium (10.5000p, 0)

• 02:46 AM ET Nov 15, 2024
  

  ANGLE presents new poster data on HER2 assay kit at the American Association for Cancer Research (AACR) Special Conference in Cancer Research in San Diego, US from 13 to 16-Nov-24 (10.0000p, 0)

• 02:24 AM ET Nov 15, 2024
  

  ANGLE announces publication of new data at American Association for Cancer Research Special Conference in Cancer Research, Liquid Biopsy (10.0000p, 0)